Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Detection of IgG-class antibodies against severe acute respiratory syndrome coronavirus 2, agent of coronavirus disease 2019 (COVID-19)
This test provides qualitative detection of serum IgG-class antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19).
This test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
Testing is only recommended in individuals at least 10 days post-symptom onset or following exposure to individuals with confirmed COVID-19.
Fact sheets for this emergency use authorization (EUA) assay can be found at the following links:
Factsheet for healthcare providers: https://www.fda.gov/media/137361/download
Factsheet for healthcare patients: https://www.fda.gov/media/137362/download
Chemiluminescence Immunoassay